May 17, 2021 RETURNING TO IN-PERSON ENGAGEMENT IS A HIGH PRIORITY FOR MOST BIOPHARMA CHIEF COMMERCIAL OFFICERS, BUT RETURNING SALES REPS TO IN-PERSON ENGAGEMENT IS A WORK-IN-PROGRESS
May 10, 2021 TRINITY LIFE SCIENCES’ NEW WHITE PAPER EXPLORES THE 2020 DICHOTOMY: AN ANALYSIS OF THE COVID-19 LAUNCH CLASS AND HOW COMMERCIAL INNOVATION FAILED TO KEEP PACE WITH SCIENTIFIC PROGRESS
May 3, 2021 WHILE THERE ARE STILL UNKNOWNS, MONOCLONAL ANTIBODIES CAN HELP IN THE FIGHT AGAINST COVID-19
April 1, 2021 LIFE SCIENCE EXECUTIVES OVERWHELMINGLY AGREE THAT INCREASED GENDER REPRESENTATION POSTIVELY IMPACTS ORGANIZATIONS
March 29, 2021 ON AVERAGE, PHARMA BRANDS ALLOCATED 66 PERCENT OF THEIR MARKETING BUDGETS TO DIGITAL IN 2020
March 3, 2021 UNCERTAINTY OF GOVERNMENT PRICING POLICIES, EVOLUTION OF PBMs, AND 340B PROGRAM EXPANSION IDENTIFIED AS TOP EXTERNAL CHALLENGES FOR PHARMA PRICING & CONTRACTING TEAMS THIS YEAR
February 24, 2021 TOP TWO CHALLENGES FOR MARKET ACCESS TEAMS IN 2021 ARE PRICING PRESSURES AND EVIDENCE GENERATION
January 19, 2021 Ninety Percent of Large Pharma Companies Initiated Artificial Intelligence/Machine Learning Projects In 2020
December 16, 2020 THREE HUNDRED FIFTY LIFE SCIENCE EXECUTIVES PARTICIPATED IN TRINITY’S BI-ANNUAL THINK TANK, THE TGaS FALL SUMMIT
